Frontage Holdings Corp

Detailed Description

Frontage Holdings Corporation, a contract research organization, provides research, analytical, and development services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers bioanalytical services, such as method development and validation, and sample analysis services; chemistry, manufacturing, and control services, including providing assistance in drug product development and analysis, as well as delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services that include study designs, execution of studies, and interpretation of the data through structural optimization in early discovery, pharmacokinetic studies in rodents, non- GLP bioanalytical studies, etc. The company also provides safety and toxicology services comprising in-vitro and in-vivo studies; bioequivalence services, which consist of designing, coordinating, and reporting of bioequivalence studies; chemistry services comprising contract research and custom synthesis services; clinical services, such as early stage clinical, BE/BA, biometric, and data management services, as well as agrochemical services. It operates in the United States, the People's Republic of China, Britain, the Netherlands, Poland, India, Japan, Korea, Israel, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.